Paloma Partners’s Elevance Health ELV Stock Holding History

Paloma Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,500	Closed	-$2.98M	–	1313
2024 Q2	$2.98M	Buy	+5,500	New	+$2.91M	0.08%	258
2024 Q1	–	Sell	-2,500	Closed	-$1.18M	–	865
2023 Q4	$1.18M	Buy	2,500 +1,000	+67%	+$462K	0.04%	380
2023 Q3	$653K	Buy	+1,500	New	+$680K	0.02%	443
2023 Q1	–	Sell	-2,400	Closed	-$1.23M	–	814
2022 Q4	$1.23M	Buy	2,400 +1,000	+71%	+$508K	0.06%	320
2022 Q3	$636K	Buy	+1,400	New	+$670K	0.03%	425
2020 Q1	–	Sell	-4,500	Closed	-$1.36M	–	1462
2019 Q4	$1.36M	Sell	4,500 -7,400	-62%	-$2.04M	0.02%	796
2019 Q3	$2.86M	Buy	+11,900	New	+$3.26M	0.06%	278
2018 Q2	–	Sell	-5,500	Closed	-$1.21M	–	1761
2018 Q1	$1.21M	Sell	5,500 -16,100	-75%	-$3.78M	0.02%	878
2017 Q4	$4.86M	Buy	21,600 +17,800	+468%	+$3.79M	0.07%	286
2017 Q3	$722K	Sell	3,800 -53,000	-93%	-$10.1M	0.01%	1333
2017 Q2	$10.7M	Buy	56,800 +38,700	+214%	+$6.95M	0.13%	117
2017 Q1	$2.99M	Buy	+18,100	New	+$2.88M	0.04%	552

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Paloma Partners's ELV Position: Q4 2024 in Review

Paloma Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2,264 shares — an estimated $1.18M sold.

Paloma Partners first reported a position in ELV in Q2 2013 and held it in 36 quarters. The position peaked at $9.99M in Q4 2017. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Paloma Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 2,264 Elevance Health shares in Q4 2024, an estimated $1.18M.
Paloma Partners first reported a position in Elevance Health in Q2 2013 and held it in 36 quarters.
Paloma Partners's Elevance Health position peaked at $9.99M in Q4 2017.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.